cyclosporine has been researched along with Acid beta-Glucosidase Deficiency in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, H; Jing, Y; Lu, W; Luan, Z; Tang, X; Wu, N; Xu, S; Zhang, B | 1 |
Bagovich, M; Binnington, B; Bond, S; De Rosa, M; Lingwood, C; Mattocks, M; Medin, J; Rasaiah, VI | 1 |
1 review(s) available for cyclosporine and Acid beta-Glucosidase Deficiency
Article | Year |
---|---|
[Treatment of Gaucher disease with allogeneic hematopoietic stem cell transplantation: report of three cases and review of literatures].
Topics: Antilymphocyte Serum; Busulfan; Child; Child, Preschool; China; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Gaucher Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mycophenolic Acid; Retrospective Studies; Transplantation Conditioning; Vidarabine | 2015 |
1 other study(ies) available for cyclosporine and Acid beta-Glucosidase Deficiency
Article | Year |
---|---|
Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1. Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model.
Topics: alpha-Galactosidase; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cyclosporine; Disease Models, Animal; Fabry Disease; Gaucher Disease; Kidney; Liver; Mice; Trihexosylceramides | 2006 |